Dacotin RTU 100 Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Oxaliplatin (100mg)
Overview Dacotin RTU 100 Injection
Colorectal cancer is treated with Dacotin RTU 100 Injection, a medication that inhibits or retards cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your individual needs and may vary. Adhere strictly to your doctor's instructions; improper use or overdose can lead to severe adverse reactions. While benefits may take weeks or months to manifest, discontinue use only under your doctor's guidance. Common side effects include nausea, fatigue, vomiting, and diarrhea. This injection can lower blood cell counts (red and white), increasing infection risk. Serious allergic reactions, such as mouth sores, rash, itching, or breathing difficulties, necessitate immediate medical attention. Regular blood tests monitor blood cell levels, as well as heart, liver, and uric acid levels. Prior to treatment, disclose any existing heart, liver, or kidney conditions, and all other medications, especially those combating infections, to your doctor. Interactions with other drugs are possible. Use during pregnancy or breastfeeding is contraindicated. Male infertility is a potential side effect; sperm freezing should be discussed with your doctor. Post-injection dizziness may impair driving ability.
Uses of Dacotin RTU 100 Injection
Colorectal cancer
Major Benefits of Dacotin RTU 100 Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
Common Side effects of Dacotin RTU 100 Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Dacotin RTU 100 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Dacotin RTU 100 Injection works:
Oncaspar (Dacotin RTU 100 Injection) is a cancer treatment that disrupts the genetic makeup (DNA and RNA) of malignant cells, thus halting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Dacotin RTU 100 Injection is undetermined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Dacotin RTU 100 Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might consider its use only if the potential benefits clearly outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Dacotin RTU 100 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Dacotin RTU 100 Injection and Oxaliplatin therapy can induce adverse reactions, including dizziness, nausea, vomiting, and other neurological symptoms impacting ambulation. These effects may impair driving ability.
KidneyCAUTION
Dacotin RTU 100 Injection requires careful administration in individuals with significant renal impairment, potentially necessitating dosage modification. Patient consultation with a physician is advised. Data regarding its use in such patients is limited; however, dosage alteration is not typically advised for those with mild to moderate kidney dysfunction.
LiverCAUTION
Individuals with hepatic impairment should use Dacotin RTU 100 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dacotin RTU 100 Injection :
Omit a Dacotin RTU 100 Injection dose? Seek your physician's advice.
Facts to Know About Dacotin RTU 100 Injection
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action class | Platinum-Based Anticancer Agents |
3,018 People bought this recently